Supply Chains as Health Infrastructure
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023JACC, 2025
- Tackling the (un)affordability of medicines for cardiometabolic risk factors worldwide: a call to actionBMJ Global Health, 2025
- Polypill Strategy in Secondary Cardiovascular PreventionNew England Journal of Medicine, 2022
- Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature reviewPLOS ONE, 2022
- Supply-side factors influencing informal payment for healthcare services in TanzaniaHealth Policy and Planning, 2021
- Establishment of the African Medicines Agency: progress, challenges and regulatory readinessJournal of Pharmaceutical Policy and Practice, 2021
- Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and AffordabilityJournal of the American Heart Association, 2020
- Improving Supply Chain for Essential Drugs in Low-Income Countries: Results from a Large Scale Randomized Experiment in ZambiaHealth Systems & Reform, 2019
- Access to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesCirculation, 2016
- Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey dataThe Lancet, 2012